{"id":"NCT00449930","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)","officialTitle":"A Multicenter, Double-Blind, Randomized Study to Evaluate the Safety and Efficacy of Sitagliptin Compared With Metformin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-03-01","primaryCompletion":"2008-07-25","completion":"2008-07-25","firstPosted":"2007-03-21","resultsPosted":"2009-08-11","lastUpdate":"2017-05-11"},"enrollment":1050,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"sitagliptin phosphate","otherNames":["MK0431"]},{"type":"DRUG","name":"Comparator: metformin hydrochloride","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"A study to evaluate the efficacy and safety of sitagliptin in comparison to a commonly used medication in patients with type 2 diabetes","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (HbA1c) at Week 24","timeFrame":"Baseline and 24 weeks","effectByArm":[{"arm":"Sitagliptin 100 mg","deltaMin":-0.43,"sd":null},{"arm":"Metformin","deltaMin":-0.57,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["20070351"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":10},"commonTop":["Any Gastrointestinal disorders","Diarrhoea"]}}